Rheumatoid Arthritis

Articles

• Angiogenesis Markers in Rheumatoid Arthritisfrom Future Rheumatol. 2008;3(2):153-159.
• Tumor Necrosis Factor Alpha Drugs in Rheumatoid Arthritis: Systematic Review and Metaanalysis of Efficacy and Safetyfrom BMC Musculoskelet Disord. 2008.
• Clinical Identification and Treatment of a Rapidly Progressing Disease State in Patients With Rheumatoid Arthritisfrom Rheumatology. 2008;47(4):392-398
• Rheumatoid Arthritis is Milder in the New Millennium: Health status in RA patients 1994-2004: Commentary from F1000from F1000 Medicine. 2008.
• New Resting Energy Expenditure Prediction Equations for Patients With Rheumatoid Arthritisfrom Rheumatology. 2008;47(4):500-506.
• Rheumatoid Arthritis, Cardiovascular Disease and Physical Exercise: A Systematic Reviewfrom Rheumatology. 2008;47(3):239-248.
• Six-Step Management of Hypertension in Patients With Rheumatoid Arthritisfrom Future Rheumatol. 2008;3(1):21-35.
• Personal and Economic Burden of Late-Stage Rheumatoid Arthritis Among Patients Treated With Adalimumab: An Evaluation From a Patient's Perspectivefrom Rheumatology. 2008;47(2):188-193.
• Video Commentary - Rheumatoid Arthritis: Treating to Targetfrom Medscape Rheumatology, Posted 04/08/2008
• Rheumatoid Arthritis Patients' Experiences of Wearing Therapeutic Footwear - A Qualitative Investigationfrom BMC Musculoskelet Disord. 2007.
• Expert Column - Early Rheumatoid Arthritis: The Potential Role for Biologic Therapyfrom Medscape Rheumatology, Posted 03/04/2008
• The Spectrum of Autoinflammatory Diseases: Recent Bench to Bedside Observationsfrom Curr Opin Rheumatol. 2008;20(1):66-75.
• The Widening Mortality Gap Between People with Rheumatoidfrom Arthritis & Rheumatism. 2007;56(11):3583-3587.
• Expert Column - Benefits and Risks of Biologic Therapies for RA: Optimizing Treatment Choicesfrom Medscape Rheumatology, Posted 01/22/2008
• Arthritis Patients Show Long-term Benefits From 3 Weeks Intensive Exercise Training Directly Following Hospital Dischargefrom Rheumatology. 2007;46(11):1712-1717
• Pregnancy and Rheumatic Diseasesfrom Rheumatology. 2007;46(11):1634-1640.
• Using the New Biologic Therapies in Rheumatoid Arthritis: Practical AspectsFuture Rheumatol. 2007;2(5):475-483.
• Is Pre-assessment for Anti-TNF Therapy in RA Necessary in the UK? Analysis of DAS28 in Six CentresRheumatology. 2007;46(10):1557-1559.
• Meditation Therapy for Rheumatoid Arthritis PatientsArthritis Care. 2007;57(7):1134-1142.
• Expert Column - Inflammatory Eye Disease: An Expert Interview With Sergio Schwartzman, MDfrom Medscape Rheumatology, Posted 09/28/2007
• A Man With Rheumatoid Arthritis and Iron-Deficiency AnemiaMedscape General Medicine. 2007;9(3):64.
• Prevalence and Associations of Hypertension and Its Control in Patients With Rheumatoid ArthritisRheumatology. 2007;42(9):1477-1482.
• Remission by Composite Scores in Rheumatoid Arthritis: Are Ankles and Feet Important?Arthritis Res Ther. 2007;9(4).
• Biologic Treatment for Rheumatoid Arthritis and the Risk of CancerArthritis & Rheumatism. 2007;56(9):2886-2895.
• Gene Therapy for Rheumatoid Arthritisfrom Future Rheumatol. 2007;2(4):403-413.
• Patient Choice and Treatment Alternatives for Arthritisfrom Arthritis & Rheumatism. 2007;56(7):2105-2110.
• Rheumatoid Arthritis and the Impact of Genetic Factors on Mortalityfrom Arthritis & Rheumatism. 2007;56(5):1408-1416
• A Newly Identified Immunosuppressive Protein in Rheumatoid Arthritisfrom Arthritis & Rheumatism. 2007;56(4):1067-1075.
• Expression and Function of Junctional Adhesion Molecule-C in Human and Experimental Arthritisfrom Arthritis Res Ther. 2007;9(4) 2007.
• Arthritis Pain, the Brain, and the Role of Emotionsfrom Arthritis & Rheumatism. 2007;56(4):1345-1354.
• Appearance Concerns Related To Depression In Patients With Rheumatic Diseasefrom Arthritis Care. 2007;57(2):303-309.
• The Link Between Rheumatoid Arthritis and Cancerfrom Arthritis & Rheumatism. 2007;56(3):790-798.
• A One Year Case Control Study in Rheumatoid Arthritis Patients Indicates a Prevention of Bone Mineral Density Loss in Both Responders and Non Responders to Infliximabfrom Arthritis Res Ther. 2007;9(3).
• Pulmonary Mycobacterium szulgai Infection and Treatment in a Patient Receiving Anti-Tumor Necrosis Factor Therapyfrom Nat Clin Pract Rheumatol. 2007;3(7):414-419
• Assessing Remission in Clinical Practicefrom Rheumatology. 2007;46(6):975-979.
• Pregnancy in Rheumatology Patients Exposed to Anti-tumour Necrosis Factor (TNF)-α Therapyfrom Rheumatology. 2007;46(4):695-698.
• The Efficacy And Tolerability Of Newer Biologics In Rheumatoid Arthritis: Best Current Evidencefrom Curr Opin Rheumatol. 2007;19(3):308-313.
• Emerging Cytokine Targets In Rheumatoid Arthritisfrom Curr Opin Rheumatol. 2007;19(3):246-251.
• Therapy Insight: Scleritis And Its Relationship To Systemic Autoimmune Diseasefrom Nat Clin Pract Rheumatol. 2007;3(4):219-226.
• Imatinib For The Treatment Of Rheumatic Diseasesfrom Nat Clin Pract Rheumatol. 2007;3(4):190-191.
• A New Classification of HLA-DRB1 Alleles Differentiates Predisposing and Protective Alleles for Autoantibody Production in Rheumatoid Arthritisfrom Arthritis Res Ther. 2007;9(2).
• CTLA-4 +49A/G and CT60 Gene Polymorphisms In Primary Sjogren Syndromefrom Arthritis Res Ther. 2007;9(2).
• Patients with Early Rheumatoid Arthritis Exhibit Elevated Autoantibody Titers Against Mildly Oxidized Low-density Lipoprotein and Exhibit Decreased Activity of Lipoprotein-associated Phospholipase A2from Arthritis Res Ther. 2007;9(1).
• Expert Column - Perspectives on Safety vs. Benefits of Biologic Therapiesfrom Medscape Rheumatology, Posted 03/30/2007
• Differential Effects on BAFF and APRIL Levels in Rituximab-treated Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritisfrom Arthritis Res Ther. 2006;8(6).
• Functional Staging And Surgical Intervention Of Elbow And Shoulder Joints In A Patient With Rheumatoid Arthritisfrom Nat Clin Pract Rheumatol. 2007;2(3):112-117.
• The International Classification of Functioning, Disability and Health in Practice in Rheumatological Care and Researchfrom Curr Opin Rheumatol. 2007;19(2):184-189.
• Predicting the Risk of Rheumatoid Arthritis for Early Arthritis Patientsfrom Arthritis & Rheumatism. 2007;56(2):433-440.
• Alendronate versus alfacalcidol in the prevention of glucocorticoid-induced bone lossfrom Nat Clin Pract Rheumatol. 2007;3(1):10-11.
• Drug Insight: Resistance to Methotrexate and Other Disease-Modifying Antirheumatic Drugs -- from Bench to Bedsidefrom Nat Clin Pract Rheumatol. 2007;3(1):26-34.
• Sex Differences and Rheumatoid Arthritisfrom Arthritis & Rheumatism. 2006;26(1):69-78.
• The Impact of Immunosuppressive Medications on Cardiovascular Events in Rheumatoid Arthritis Patientsfrom Arthritis & Rheumatism. 2006;54(12):3790-3798.
• Expert Column - Update on Imaging and Radiographic Measurements: Assessment of Symptom Presentation and Disease Progressionfrom Medscape Rheumatology, Posted 12/14/2006
• Stem Cells in Inflammatory Diseasefrom Curr Opin Rheumatol. 2006;18(6):618-619.
• Optimizing Efficacy -- Perspectives on Switching to/Between Biologic Response Modifiers: An Expert Interview With Martin J. Bergman, MD, FACR, FACPfrom Medscape Rheumatology, Posted 11/01/2006
• Serum, Urinary, and Salivary Nitric Oxide in Rheumatoid Arthritis: Complexities of Interpreting Nitric Oxide Measuresfrom Arthritis Res Ther. 2006;8(5).
• Rheumatoid Arthritis and Sex Differencesfrom Arthritis & Rheumatism. 2006;54(10):3087-3094.
• Expert Column - Ankylosing Spondylitisfrom Medscape Rheumatology, Posted 09/28/2006
• Psoriatic Arthritis and Rheumatoid Arthritis: Findings in Contrast-Enhanced MRIfrom Am J Roentgenol. 2006;187(2):351-357.
• Diagnosing and Treating Fibromyalgia in a Patient With Rheumatoid Arthritis. An Expert Interview With Daniel J. Clauw, MDfrom Medscape Rheumatology, Posted 09/21/2006
• TNF-Inhibitor Therapy and Risk for Side Effects: An Expert Interview With Arthur Kavanaugh, MDfrom Medscape Rheumatology, Posted 09/11/2006
• Assessment of Coxib Ultilization for Nonsteroidal Antiinflammatory Drug Gastroprotection Prior to the Coxib Market Withdrawalsfrom Arthritis Care. 2006;55(4):543-550.
• Science As Experiment; Science As Observationfrom Nat Clin Pract Rheumatol. 2006;2(6):286-287.
  
• Osteoclasts, Rheumatoid Arthritis, and Osteoimmunologyfrom Curr Opin Rheumatol. 2006;18(4):419-426.
• New Genes Implicated in Rheumatoid Arthritisfrom Arthritis & Rheumatism. 2006;54(7):2047-2060.
• Traditional DMARD Therapy: Is it Sufficient?from Arthritis Res Ther. 2006.
• Establishing Trust Between Physicians and Patients With Rheumatic Diseasesfrom Medscape Rheumatology, Posted 06/27/2006
• Disparities Among Children With Juvenile Rheumatoid Arthritisfrom Arthritis & Rheumatism. 2006;55(3):378-384.
• Scheuermann's Disease and Melkersson-Rosenthal Syndromefrom Appl Radiol. 2006;35(6):46-47.
• Myocardial Microangiopathy in a Patient with Rheumatoid Arthritisfrom Nat Clin Pract Cardiovasc Med. 2006;3(6):339-343.
• Yoga as a Complementary Therapyfrom Geriatrics Aging. 2006;9(3):190-194.
• Basic Calcium Phosphate Crystals: Pathways to Joint Degenerationfrom Curr Opin Rheumatol. 2006;18(2):187-192.
  
• Imaging Outcomes and Their Role in Determining Outcomes in Osteoarthritis and Rheumatoid Arthritisfrom Curr Opin Rheumatol. 2006;18(2):157-162.
• Methotrexate in Rheumatoid Arthritis is Frequently Effective, Even If Re-employed After a Previous Failurefrom Arthritis Res Ther. 2006;8(2):R46.
• New Insights into the Link Between Rheumatoid Arthritis and Cancerfrom Arthritis & Rheumatism. 2006;54(3):692-701.
• Using Statins to Potentially Treat Rheumatoid Arthritisfrom Arthritis & Rheumatism. 2006;54(2):579-586.
• Musculoskeletal Manifestations and Autoimmune Diseases Related to New Biologic Agentsfrom Curr Opin Rheumatol. 2006;18(1):96-100.
• Detailed Analysis of the Variability of Peptidylarginine Deiminase Type 4 in German Patients with Rheumatoid Arthritis: A Case-Control Studyfrom Arthritis Res Ther. 2006;8(2):R34.
  
• A New Model for an Etiology of Rheumatoid Arthritis: Smoking May Trigger HLA-DR (Shared Epitope)-Restricted Immune Reactions to Autoantigens Modified by Citrullinationfrom Arthritis & Rheumatism. 2006;54(1):53-61.
• The PREMIER Study: Combination Therapy for Achieving Remission of Early RAfrom Arthritis & Rheumatism. 2006;54(1):41-52.
• Intra-articular Injection of Recombinant TRAIL Induces Synovial Apoptosis and Reduces Inflammation in a Rabbit Knee Model of Arthritisfrom Arthritis Res Ther. 2005;8(1).
  
• T-Cell Costimulatory Pathway -- Targeted Inhibition and Impact on RA Progression: An Expert Interview With Salvatore Albani, MD, PhDfrom Medscape Rheumatology, Posted 12/15/2005
• Biologic Therapies for RA: Current Challenges, Future Direction -- An Expert Interview With Stanley Cohen, MDfrom Medscape Rheumatology, Posted 12/01/2005
• Earlier Use of Biologics, DMARDs in Juvenile Arthritis Linked to More Robust Improvementfrom Medscape Medical News, Posted 11/18/2005
  
• Clinical and Radiographic Outcomes of Four Different Treatment Strategies in Patients With Early Rheumatoid Arthritis (the Best Study): A Randomized, Controlled Trialfrom Arthritis & Rheumatism. 2005;52(11):3381-3390.
  
• Is Rheumatoid Arthritis Becoming Milder?from Arthritis & Rheumatism. 2005;52(9):2616-2624.
• Copper Chelation With Tetrathiomolybdate Suppresses Adjuvant-Induced Arthritis and Inflammation-Associated Cachexia in Ratsfrom Arthritis Res Ther. 2005;7(6):R1174-R1182.
• Sex Hormone Modulation of Cell Growth and Apoptosis of the Human Monocytic/Macrophage Cell Linefrom Arthritis Res Ther. 2005;7(5):R1124-R1132.
• Update on the Pathogenesis and Treatment of Systemic Onset Juvenile Rheumatoid Arthritisfrom Curr Opin Rheumatol. 2005;17(5):612-616.
• Rheumatoid Arthritis is an Independent Risk Factor for Multi-vessel Coronary Artery Disease: A Case Control Studyfrom Arthritis Res Ther. 2005;7(5):R984-R991.
  
• Rheumatoid Arthritis: A Self-Assessment Casefrom ACP Medicine, Posted 07/26/2005
• Changes in the Meaning of Pain with the Use of Guided Imageryfrom Pain Manag Nurs. 2005;6(2):58-67.
• Antibodies to Citrullinated Proteins and Differences in Clinical Progression of Rheumatoid Arthritisfrom Arthritis Res Ther. 2005;7(5):R949-R958.
• Early Arthritis and Infectionfrom Curr Opin Rheumatol. 2005;17(4):433-439.
• Serum Antibodies to Oral Anaerobic Bacteria in Patients With Rheumatoid Arthritisfrom Medscape General Medicine, Posted 06/16/2005
  
• Study: Vioxx, Celebrex Were Widely Overprescribedfrom Drug Benefit Trends. 2005; 17 (2): 56.
• New Strategies for Immunosuppression: Interfering With Cytokines by Targeting the Jak/Stat Pathwayfrom Curr Opin Rheumatol. 2005; 17 (3): 305-311.
• Emerging Biologic Therapies in Rheumatoid Arthritis: Cell Targets and Cytokinesfrom Curr Opin Rheumatol. 2005; 17 (3): 274-279.
• Conditions During TNF-alpha-Blocking Therapy in Patients With Rheumatoid Arthritis: A Prospective Studyfrom Arthritis Res Ther. 2005; 7 (4): R666-R676.
  
• Peripheral Blood but Not Synovial Fluid Natural Killer T Cells Are Biased Towards a Th1-like Phenotype in Rheumatoid Arthritisfrom Arthritis Res Ther. 2005; 7 (3): R493-R502.
• Levels of Gastrin-Releasing Peptide and Substance P in Synovial Fluid and Serum Correlate With Levels of Cytokines in Rheumatoid Arthritisfrom Arthritis Res Ther. 2005; 7 (3): R416-R426.
• Gene Expression Profiling in Murine Autoimmune Arthritis During the Initiation and Progression of Joint Inflammationfrom Arthritis Res Ther. 2005; 7 (2): R196-R207
• Chemokine Receptors in the Rheumatoid Synovium: Upregulation of CXCR5from Arthritis Res Ther. 2005; 7(2):R217-R229.
• Natural Killer Cell Dysfunction Is a Distinguishing Feature of Systemic Onset Juvenile Rheumatoid Arthritis and Macrophage Activation Syndromefrom Arthritis Res The. 2004. 7(1):R30-R3.
• Celecoxib Linked to Increased Cardiovascular Riskfrom Medscape Medical News, Posted 12/17/2004
• Serum Cathepsin K Levels of Patients With Longstanding Rheumatoid Arthritis: Correlation With Radiological Destructionfrom Arthritis Res Ther.2004;7:R65-R70.
• Relaxin's Induction of Metalloproteinases is Associated With the Loss of Collagen and Glycosaminoglycans in Synovial Joint Fibrocartilaginous Explantsfrom Arthritis Res Ther. 2004;7:R1-R11.
• Unlike Rofecoxib, Celecoxib Not Linked to Increased Risk of MIfrom Medscape Medical News, Posted 12/08/2004
• Antibodies Against the CB10 Fragment of Type II Collagen In Rheumatoid Arthritisfrom Arthritis Res Ther. 2004;6:R477-R483.
• Adverse Reactions to Biological Modifiersfrom Curr Opin Allergy Clin Immunol. 2004;4:277-283.
• Diosgenin, a Plant Steroid, Induces Apoptosis in Human Rheumatoid Arthritis Synoviocytes With Cyclooxygenase-2 Overexpressionfrom Arthritis Res Ther. 2004;6:R373-R383.
• Long-Term Risks Associated With Biologic Response Modifiers Used in Rheumatic Diseasesfrom Curr Opin Rheumatol. 2004;16:199-205.
• Measurement of Global Functional Performance in Patients with Rheumatoid Arthritis Using Rheumatology Function Testsfrom Arthritis Res Ther. 2004;6:315-325.
• A Combination of Autoantibodies to Cyclic Citrullinated Peptide (CCP) and HLA-DRB1 Locus Antigens is Strongly Associated with Future Onset of Rheumatoid Arthritisfrom Arthritis Res Ther. 2004;6:303-308.
• Pathway to Independence: Physical Therapy for Patients With Rheumatoid Arthritisfrom Medscape General Medicine, Posted 05/17/2004
• Physiotherapy in Rheumatoid Arthritisfrom Medscape General Medicine, Posted 05/17/2004
• B Cells as Therapeutic Targets for Rheumatic Diseasesfrom Curr Opin Rheumatol. 2004;16:180-185.
• Multidisciplinary Team Care and Outcomes in Rheumatoid Arthritisfrom Curr Opin Rheumatol. 2004;16:153-156.
• Enhanced Osteoclast Development in Collagen-Induced Arthritis in Interferon-y Receptor Knock-Out Mice as Related to Increased Splenic CD11b+ Myelopoiesisfrom Arthritis Res Ther. 2004;6:R220-R231.
• Treatment With Recombinant Interferon-B Reduces Inflammation and Slows Cartilage Destruction in the Collagen-Induced Arthritis Model of Rheumatoid Arthritisfrom Arthritis Res Ther. 2004;6:R239-R249.
• Induction of IL-10-Producing CD4+CD25+ T Cells in Animal Model of Collagen-Induced Arthritis by Oral Administration of Type II Collagenfrom Arthritis Res Ther. 2004;6:R213-R219.
• Association of a Specific Haplotype Across the Genes MMP1 and MMP3 With Radiographic Joint Destruction in Rheumatoid Arthritisfrom Arthritis Res Ther. 2004;6:R199-R207.
• Short-Term Efficacy and Safety of Leflunomide in the Treatment of Active Rheumatoid Arthritis in Everyday Clinical Usefrom Clin Drug Invest. 2004;24:103-112.
• Effectiveness and Safety of Strength Training in Rheumatoid Arthritisfrom Curr Opin Rheumatol. 2004;16:132-137.
• IL-17 Induces Production of IL-6 and IL-8 in Rheumatoid Arthritis Synovial Fibroblasts via NF-kB- and PI3 kinase/Akt-Dependent Pathwaysfrom Arthritis Res Ther. 2004;6:R120-R128.
• Inhibition of Established Collagen-Induced Arthritis With a Tumour Necrosis Factor-a Inhibitor Expressed From a Self-Contained Doxycycline Regulated Plasmidfrom Arthritis Res Ther. 2004;6:R103-R113.
• Susceptibility to Collagen-Induced Arthritis is Modulated by TGFß Responsiveness of T Cellsfrom Arthritis Res Ther. 2004;6:R114-R119.
• Decreased Response to IL-12 and IL-18 of Peripheral Blood Cells in Rheumatoid Arthritisfrom Arthritis Res Ther. 2003;6:R39-R45.
• Direct and Indirect Costs of Arthritis and Other Rheumatic Conditions; United States, 1997from MMWR. 2003;52:1124-1127.
• Novel Approaches to Gene Expression Analysis of Active Polyarticular Juvenile Rheumatoid Arthritisfrom Arthritis Res Ther. 2003;6:R15-R32.
• Differential Gene Expression in Pristane-Induced Arthritis Susceptible DA Versus Resistant E3 Ratsfrom Arthritis Res Ther. 2003;5:R361-R372.
• Impact of VIP and cAMP on the Regulation of TNF-a and IL-10 Production: Implications for Rheumatoid Arthritisfrom Arthritis Res Ther. 2003;5:R317-R328.
• Introduction to the Rheumatic Diseasesfrom WebMD Scientific American Medicine. 2003.
• Cytokine Blockers for Inflammatory Arthritisfrom WebMD Scientific American Medicine. 2003.
• Electrophoretic Characterization of Species of Fibronectin Bearing Sequences From the N-Terminal heparin-Binding Domain in Synovial Fluid Samples From Patients With Osteoarthritis and Rheumatoid Arthritisfrom Arthritis Res Ther. 2003;5:329-339.
• Etanercept Versus Etanercept Plus Methotrexate: A Registry-Based Study Suggesting that the Combination Is Clinically More Effaciousfrom Arthritis Res Ther. 2003;5:R347-R351.
• Differentiation of Naive CD4+ T Cells Towards T Helper 2 Cells is Not Impaired in Rheumatoid Arthritis Patientsfrom Arthritis Res Ther. 2003;5:269-276.
• High CXCR3 Expression in Synovial Mast Cells Associated With CXCL9 and CXCL10 Expression in Inflammatory Synovial Tissues of Patients With Rheumatoid Arthritisfrom Arthritis Res Ther. 2003;5:241-252.
• Extracellular Mitochondrial DNA and Oxidatively Damaged DNA in Synovial Fluid of Patients With Rheumatoid Arthritisfrom Arthritis Res Ther. 2003;5:234-240.
• MEDLINE Abstracts: Nonpharmacologic Approaches to Arthritis Painfrom Medscape Neurology & Neurosurgery, Posted 09/12/2003
• Rheumatoid Arthritisfrom WebMD Scientific American Medicine. 2003.
• Quality-of-Life Measurements in Juvenile Rheumatoid Arthritis Patients Treated With Etanerceptfrom Clin Drug Invest. 2003;23:511-518.
• Hormone Replacement Therapy In Rheumatoid Arthritis Is Associate With Lower Serum Levels of Soluble IL-6 Receptor and Higher Insulin-Like Growth Factor 1from Arthritis Res Ther. 2003;5:R202-R209.
• Regulation and Localization of Endogenous Human Tristetraprolinfrom Arthritis Res Ther. 2003;5:R214-R225.
• Upregulated Hypoxia Inducible Factor-1a and -2a Pathway in Rheumatoid Arthritis and Osteoarthritisfrom Arthritis Res Ther. 2003;5:R193-R201.
• Subcorneal Pustular Dermatosis Developing in a Patient With Rheumatoid Arthritis; Rheumatoid, Antimicrosomal, and Antimitochondrial Autoantibodies; and a Goiterfrom SKINmed. 2003;2:258-259.
• Effects of Rheumatoid Arthritis on Bonefrom Curr Opin Rheumatol. 2003;15:469-475.
• Silencing Autoimmunity in Multiple Sclerosis, Lupus, and Rheumatoid Arthritisfrom Medscape Molecular Medicine, Posted 06/18/2003.
• Is There Still a Role for Traditional Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis?from Curr Opin Rheumatol. 2003;15:185-192.
• Medical Management of Rheumatoid Arthritisfrom Clinician Reviews. 2003;13:48-53.
• New Role for an Old Friend: Prednisone Is a Disease-Modifying Agent in Early Rheumatoid Arthritisfrom Curr Opin Rheumatol. 2003;15:193-196.
• Upcoming Biologic Agents for the Treatment of Rheumatic Diseasesfrom Curr Opin Rheumatol. 2003;15:226-236.
• Rheumatoid Arthritis - Making the Diagnosisfrom Clinician Reviews. 2003;13:58-63.
• The Role of Biologics in Optimizing RA Treatment: A Return to Monotherapy?from Medscape CME Circle, Posted 03/29/2002
• Biological Response Modifiers in the Management of Rheumatoid Arthritisfrom Am J Health-Syst Pharm. 2003;60:346-355.
• Clinical Epidemiology: Diagnostic and Prognostic Testsfrom Curr Opin Rheumatol. 2003;15:104-109.
• Cost-Effectiveness, Cost-Utility, and Cost-Benefit Studies in Rheumatology: A Review of the Literature, 2001-2002from Curr Opin Rheumatol. 2003;15:127-131.
• Intense Immunosuppression and Stem-Cell Transplantation for Patients With Severe Rheumatic Autoimmune Disease: A Reviewfrom Cancer Control. 2003;10:57-65.
• A Longitudinal Study of Rheumatoid Arthritis in South Africansfrom Medscape General Medicine, Posted 02/05/2003